
Results
4
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
4 companies
Pharma Mar
Market Cap: €1.6b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€91.00
7D
3.0%
1Y
20.5%
Oryzon Genomics
Market Cap: €216.3m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.
ORY
€2.79
7D
4.1%
1Y
3.3%
Ercros
Market Cap: €312.3m
Manufactures and sells chemical and pharmaceutical products in Spain and internationally.
ECR
€3.42
7D
0%
1Y
21.3%
Adolfo Domínguez
Market Cap: €45.8m
Engages in the design, manufacture, acquisition, sale, marketing, retail, import, and export of ready-made garments, footwear, handbags and accessories, household linen, furniture, and decorative objects.
ADZ
€4.96
7D
2.1%
1Y
8.8%